🇺🇸 FDA
Pipeline program

INO-4201

EBOV-001

Phase 1 mab completed

Quick answer

INO-4201 for Ebola Vaccine is a Phase 1 program (mab) at INOVIO PHARMACEUTICALS, INC. with 1 ClinicalTrials.gov record(s).

Program details

Company
INOVIO PHARMACEUTICALS, INC.
Indication
Ebola Vaccine
Phase
Phase 1
Modality
mab
Status
completed

Clinical trials